Published in Sci Rep on June 11, 2015
Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia | NCT00137111
Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes. Front Immunol (2017) 0.75
Transplant genetics and genomics. Nat Rev Genet (2017) 0.75
Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep (1966) 48.83
1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant (1995) 24.01
Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature (1996) 11.46
The analysis of failure times in the presence of competing risks. Biometrics (1978) 11.22
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood (2007) 9.82
Graft-versus-host disease. Lancet (2009) 8.78
Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity. Cell (1993) 7.41
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nat Genet (2011) 4.93
The power of the 3' UTR: translational control and development. Nat Rev Genet (2003) 4.84
Hedgehog signals regulate multiple aspects of gastrointestinal development. Development (2000) 3.77
Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol (2007) 3.65
Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med (2003) 3.57
Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol (2012) 3.50
Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med (1978) 3.46
Sonic hedgehog regulates branching morphogenesis in the mammalian lung. Curr Biol (1998) 3.29
Lipoxygenase mRNA silencing in erythroid differentiation: The 3'UTR regulatory complex controls 60S ribosomal subunit joining. Cell (2001) 3.19
Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation. N Engl J Med (2014) 3.08
Gli proteins in development and disease. Annu Rev Cell Dev Biol (2011) 3.04
Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med (2009) 2.95
Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA (2009) 2.72
Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev Cancer (2004) 2.65
The output of Hedgehog signaling is controlled by the dynamic association between Suppressor of Fused and the Gli proteins. Genes Dev (2010) 2.60
Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved. Genes Dev (2009) 2.59
A mechanism for vertebrate Hedgehog signaling: recruitment to cilia and dissociation of SuFu-Gli protein complexes. J Cell Biol (2010) 2.47
Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood (2010) 2.37
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia. Proc Natl Acad Sci U S A (2009) 1.92
Dissolution of the maskin-eIF4E complex by cytoplasmic polyadenylation and poly(A)-binding protein controls cyclin B1 mRNA translation and oocyte maturation. EMBO J (2002) 1.92
Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia. Blood (2012) 1.90
Evaluation of published single nucleotide polymorphisms associated with acute GVHD. Blood (2012) 1.88
Cardiac and CNS defects in a mouse with targeted disruption of suppressor of fused. Development (2005) 1.75
HapMap scanning of novel human minor histocompatibility antigens. Blood (2008) 1.75
Negative regulation of Gli1 and Gli2 activator function by Suppressor of fused through multiple mechanisms. Differentiation (2005) 1.68
Statistical significance threshold criteria for analysis of microarray gene expression data. Stat Appl Genet Mol Biol (2004) 1.62
The prothrombin gene variant G20210A but not factor V leiden may be associated with veno-occlusive disease following BMT. Bone Marrow Transplant (1999) 1.43
Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood (2002) 1.41
Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood (2002) 1.39
Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. Blood (2006) 1.30
A cell line model for the differentiation of human dendritic cells. Biochem Biophys Res Commun (2005) 1.28
A TB-RBP and Ter ATPase complex accompanies specific mRNAs from nuclei through the nuclear pores and into intercellular bridges in mouse male germ cells. Dev Biol (2002) 1.23
Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT. Blood (2012) 1.22
Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine 245. Blood (2009) 1.18
Current and emerging strategies for the prevention of graft-versus-host disease. Nat Rev Clin Oncol (2014) 1.15
Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. Blood (2002) 1.12
Survival and function of human thymic dendritic cells are dependent on autocrine Hedgehog signaling. J Leukoc Biol (2008) 0.98
CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia. J Clin Oncol (2008) 0.96
Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory function. J Hematol Oncol (2008) 0.93
Pharmacogenetic analysis of liver toxicity after busulfan/cyclophosphamide-based allogeneic hematopoietic stem cell transplantation. Anticancer Res (2008) 0.88
Sonic Hedgehog in cancer stem cells: a novel link with autophagy. Biol Res (2012) 0.85
Polymorphism in the interleukin-7 receptor-alpha and outcome after allogeneic hematopoietic cell transplantation with matched unrelated donor. Scand J Immunol (2013) 0.84
Next generation treatment of acute graft-versus-host disease. Leukemia (2014) 0.83
Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant (2011) 0.83
Antagonistic and cooperative actions of Kif7 and Sufu define graded intracellular Gli activities in Hedgehog signaling. PLoS One (2012) 0.83
Genomic studies of GVHD-lessons learned thus far. Bone Marrow Transplant (2012) 0.83
Molecular determinant-based typing of KIR alleles and KIR ligands. Clin Immunol (2011) 0.83
Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease. Blood (2012) 0.78
Genomic and proteomic analysis of allogeneic hematopoietic cell transplant outcome. Seeking greater understanding the pathogenesis of GVHD and mortality. Biol Blood Marrow Transplant (2009) 0.78
Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules. Bone Marrow Transplant (1990) 0.77
Regulation of HLA class II expression prevents allogeneic T-cell responses. Tissue Antigens (2011) 0.77
The biology of pediatric acute megakaryoblastic leukemia. Blood (2015) 0.84
Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels. Blood (2015) 0.80
Haploinsufficient loss of multiple 5q genes may fine-tune Wnt signaling in del(5q) therapy-related myeloid neoplasms. Blood (2015) 0.79
Murine hemogenic endothelial precursors display heterogeneous hematopoietic potential ex vivo. Exp Hematol (2017) 0.76
Bithalamic Gliomas May Be Molecularly Distinct From Their Unilateral High-Grade Counterparts. Brain Pathol (2016) 0.75